
ARWR+308.39%14.3%

DYN+107.47%14.3%

FDMT+123.27%14.3%

IONS+39.94%14.3%

LRMR+6.91%14.3%

SLN+148.04%14.3%

TWST+409.23%14.3%
As of Aug 24, 2026, 4:53 AM ET
Biotech '25: RNA-Based/Genetic Medicine Constituents
4D Molecular Therapeutics, Inc.FDMT | 14.3% | -1.68% | 38.01% | 57.20% | 55.50% | 111.07% | 63.87% | 382.62% | 5.82% | -45.30% | 123.27% | $827.5M |
Arrowhead Pharmaceuticals, Inc.ARWR | 14.3% | -0.41% | -2.39% | 1.76% | 2.91% | 31.21% | 37.68% | 586.45% | 251.53% | 40.16% | 308.39% | $12.27B |
Dyne Therapeutics, Inc.DYN | 14.3% | 0.46% | -2.28% | 6.79% | 3.65% | 33.44% | 67.09% | 163.37% | -43.91% | 57.61% | 107.47% | $4.87B |
Ionis Pharmaceuticals, Inc.IONS | 14.3% | 1.69% | 7.80% | 5.64% | 15.40% | -24.48% | -26.38% | 108.08% | 27.32% | 53.06% | 39.94% | $9.93B |
Larimar Therapeutics, Inc.LRMR | 14.3% | 0.48% | -3.02% | 4.50% | 9.42% | 9.71% | -21.28% | 90.00% | -46.82% | -70.83% | 6.91% | $434.2M |
Silence Therapeutics plcSLN | 14.3% | 0.76% | -9.85% | 20.42% | 26.50% | 118.26% | 143.93% | 359.17% | -18.09% | -41.95% | 148.04% | $626.8M |
Twist Bioscience CorporationTWST | 14.3% | 6.79% | 18.25% | 61.28% | 59.03% | 358.98% | 210.29% | 281.03% | 233.46% | 34.69% | 409.23% | $9.07B |
| Theme return | — | 1.16% | 6.65% | 24.83% | 25.32% | 82.40% | 62.91% | 356.30% | 76.41% | 132.65% | 188.75% | — |
| Average | 14.3% | 1.16% | 6.65% | 22.51% | 24.63% | 91.17% | 67.89% | 281.53% | 58.47% | 3.92% | 163.32% | $5.43B |
| Median | 14.3% | 0.48% | -2.28% | 6.79% | 15.40% | 33.44% | 63.87% | 281.03% | 5.82% | 34.69% | 123.27% | $4.87B |
| Std Dev | 0.0% | 2.50% | 15.34% | 23.90% | 21.94% | 119.40% | 79.13% | 164.73% | 118.96% | 50.25% | 134.25% | $4.63B |
| Min | 14.3% | -1.68% | -9.85% | 1.76% | 2.91% | -24.48% | -26.38% | 90.00% | -46.82% | -70.83% | 6.91% | $434.2M |
| Max | 14.3% | 6.79% | 38.01% | 61.28% | 59.03% | 358.98% | 210.29% | 586.45% | 251.53% | 57.61% | 409.23% | $12.27B |
| % Positive Tickers | 71.43% | 42.86% | 100.00% | 100.00% | 85.71% | 71.43% | 100.00% | 57.14% | 57.14% | 100.00% |
About this theme
Biotech '25: RNA-Based/Genetic Medicine tracks 7 publicly listed stocks in this theme: ARWR, DYN, FDMT, IONS, LRMR, SLN, TWST. See the constituent table for details.
